Internal Medicine, Rheumatology · Miami, FL
NPI
1043223902
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3659 S Miami Ave Ste 3005
Miami, FL, 33133
Phone (305) 860-6260
Groups this clinician bills Medicare through
Medicare paid, 2024
$307K
20,177 services
Medicare patients, 2024
250
Average age 76
Drug cost, 2024
$5.2M
4,813 prescriptions
Company payments, 2025
$2,649
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos M Alonso was code J0897 (injection, denosumab, 1 mg), 2,520 times for 23 patients. In total Carlos M Alonso billed 20,177 services in 47 codes, and Medicare paid $307K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,520 | 23 | $20.26 | $51K |
| J7332 Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg | Office | 1,340 | 14 | $8.09 | $11K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,340 | 18 | $0.11 | $141 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 822 | 67 | $0.73 | $602 |
| 99213 Office E&M - Established | Office | 207 | 123 | $68.80 | $14K |
| 20610 Joint Injection | Office | 186 | 69 | $59.86 | $11K |
| 99214 Office E&M - Established | Office | 182 | 89 | $100.26 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 99 | 44 | $12.81 | $1,268 |
| 96372 Injection Administration | Office | 72 | 27 | $11.73 | $845 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 65 | 13 | $5.06 | $329 |
| 99204 Office E&M - New | Office | 60 | 60 | $130.22 | $7,813 |
| 96365 Intravenous Infusion, Hydration | Office | 55 | 22 | $50.74 | $2,791 |
| 96413 Chemotherapy Administration | Office | 47 | 12 | $106.12 | $4,988 |
| 20550 Musculoskeletal | Office | 22 | 15 | $44.19 | $972 |
| 99212 Office E&M - Established | Office | 15 | 11 | $38.66 | $580 |
By year: 2022 $425K for 26,714 services; 2023 $357K for 28,712 services; 2024 $307K for 20,177 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carlos M Alonso prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 764 prescriptions and refills. In total Carlos M Alonso wrote 4,813 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 764 | 1,208 | 154 | $6,170 |
| Prednisone Generic | 647 | 997 | 158 | $2,771 |
| Folic Acid Generic | 283 | 651 | 86 | $1,113 |
| Diclofenac Sodium Generic | 185 | 225 | 60 | $8,410 |
| Gabapentin Generic | 166 | 291 | 70 | $1,694 |
| Enbrel Sureclick Etanercept | 160 | 160 | 14 | $912K |
| Hydroxychloroquine Sulfate Generic | 154 | 300 | 38 | $2,081 |
| Orencia Clickject Abatacept | 147 | 147 | 12 | $628K |
| Prolia Denosumab | 133 | 798 | 86 | $233K |
| Pregabalin Generic | 131 | 151 | 37 | $2,144 |
| Celecoxib Generic | 125 | 180 | 50 | $2,765 |
| Risedronate Sodium Generic | 111 | 260 | 38 | $12K |
| Meloxicam Generic | 102 | 124 | 46 | $172 |
| Duloxetine Hcl Generic | 95 | 182 | 33 | $1,532 |
| Ibuprofen Generic | 88 | 106 | 30 | $673 |
Brand drugs: 1,253 claims; generic drugs: 3,532 claims; opioid claims: 42.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos M Alonso $2,649 ($2,649 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $694.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 19 | $694 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $298 |
| UCB, Inc. UCB.BR | 11 | $289 |
| Amgen Inc. AMGN | 13 | $273 |
| Mallinckrodt Hospital Products Inc. | 6 | $204 |
| GlaxoSmithKline, LLC. GSK | 9 | $183 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $110 |
| Aurinia Pharma U.S., Inc. AUPH | 4 | $106 |
| Radius Health, Inc. | 5 | $97.31 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $95.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.